title: Prothrombin fragment F 1+2 levels are high in NIDDM patients independently of the Hb A1 c.
authors.forename: F
authors.initials: F
authors.lastname: Marongiu
authors.forename: F
authors.initials: F
authors.lastname: Mascia
authors.forename: G
authors.initials: G
authors.lastname: Mameli
authors.forename: R
authors.initials: R
authors.lastname: Cirillo
authors.forename: A
authors.initials: A
authors.lastname: Balestrieri
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001778:Blood Coagulation Disorders / Q000097:blood / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D004198:Disease Susceptibility / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000032:analysis*; D011516:Prothrombin / Q000032:analysis*
chemical_list: D006442:Glycated Hemoglobin; D010446:Peptide Fragments; D011516:Prothrombin; C045879:prothrombin fragment 1.2